Back to Company Profile
Alpha

Alpha Profiles · Company Profile

Aquestive Therapeutics, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/aquestive-therapeutics-inc

Aquestive Therapeutics, Inc. logo
Entity
Public listing published
Primary listing
NASDAQ: AQST
Verification
Partially verified
Last reviewed
2026-09-17T04:46:14.348898+00:00

Overview

Alpha's canonical identity and public leadership record for Aquestive Therapeutics, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

9 public records
AE
A. Ernest Toth, Jr.

Chief Financial Officer

State
confirmed
Effective
Date not stated
Confidence
94%
Evidence
AQST executive roster sourceMay 3, 2026
AM
A. Mark Schobel

Chief Innovation and Technology Officer

State
confirmed
Effective
Date not stated
Confidence
94%
Evidence
AQST executive roster sourceMay 3, 2026
CN
Carl N. Kraus

Chief Medical Officer

State
confirmed
Effective
Date not stated
Confidence
94%
Evidence
AQST executive roster sourceMay 3, 2026
CJ
Cassie Jung

Chief Operating Officer

State
confirmed
Effective
Date not stated
Confidence
94%
Evidence
AQST executive roster sourceMay 3, 2026
MT
Melina T. Cioffi

Senior Vice President Regulatory Affairs

State
confirmed
Effective
Date not stated
Confidence
94%
Evidence
AQST executive roster sourceMay 3, 2026
PB
Peter Boyd

Senior Vice President Information Technology, Human Resources and Communications

State
confirmed
Effective
Date not stated
Confidence
94%
Evidence
AQST executive roster sourceMay 3, 2026
SK
Sherry Korczynski

Senior Vice President Sales and Marketing

State
confirmed
Effective
Date not stated
Confidence
94%
Evidence
AQST executive roster sourceMay 3, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 17, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.

Board roles

7 public records

Source record

Alpha canonical company public projection

Supports Company identity, Published leadership, Entity status boundary

Reviewed 2026-09-17T04:46:14.348898+00:00

Generated 2026-09-17T11:40:30.539Z

Data as of 2026-09-17T04:46:14.348898+00:00

https://registry.alpha.ac/companies/aquestive-therapeutics-inc